To assess the in vivo impact of SNRPD3 depletion in neuroblastoma, pooled Dox-inducible control shRNA (shControl) or two SNRPD3 shRNA (shSNRPD3 #1 and #2) SK-N-BE(2)-C cell lines were generated. The gene discussed is SNRPD3; the disease is neuroblastoma.